Further, 50% of these patients demonstrated the presence of both KIT D816V and TET2 mutations, suggesting that the high frequency of cooperating (TET2 – KIT D816V) mutations may contribute to the heterogeneity observed in SM patients. Here, TET2 is linked to systemic mastocytosis.